The legal industry has been left permanently altered from the pandemic. Five thought leaders provide their exclusive take into what these changes look like from the inside
While WTO member states have expressed general sympathy for the goal to provide broad access to vaccine technology during the pandemic, Germany continues to favour patent protection over compulsory licensing.
IAM examines the approaches taken by – and the issues facing – the leading companies in the race to find effective coronavirus inoculations
19 November 2020
A major PTAB defeat and uncertainties around US government funding cast a royalties shadow over the company's ability to monetise the breakthrough
16 November 2020
IP team led by John Mulgrew is taking a hard look at inventorship within the company as part of an effort to attract and retain a diverse R&D talent pool
12 November 2020
Company CEO proclaims “a great day for science and humanity”, but there are patent, know-how and data uncertainties to overcome
09 November 2020
Leading lights from Canon, Hitachi and NTT among those who will discuss the way forward at virtual IPBC Japan conference
06 November 2020
Pharma and biotech companies can learn from how strategies are developed in other sectors, but will still have to forge their own paths to meet new challenges
31 October 2020
As the covid-19 pandemic continues to upend education in the US and beyond, there is an opportunity to create a new normal in how IP is taught, says Megan Carpenter, Dean of the Franklin Pierce School of Law
24 October 2020
WHO-backed proposal seeks to suspend key multilateral protections for patents and trade secrets
20 October 2020
The leading vaccine innovator has won plaudits for its commitment not to enforce its coronavirus-related IP rights against other mRNA inventors
15 October 2020
Spinal surgery pioneer tells IAM that it is important to ensure the US public does not get a rough deal from rights owners
08 October 2020
Unlock unlimited access to all IAM content
